Close Menu

About Us

GenomeWeb is an independent online news organization based in New York. Since 1997, GenomeWeb has served the global community of scientists, technology professionals, and executives who use and develop the latest advanced tools in molecular biology research and molecular diagnostics.

GenomeWeb’s editorial mission is to cover the scientific and economic ecosystem spurred by the advent of high-throughput genome sequencing. We operate the largest online newsroom focused on advanced molecular research tools in order to provide our readers with exclusive news and in-depth analysis of this rapidly evolving market.

GenomeWeb users can be found in major scientific organizations around the world, including biopharmaceutical companies, research universities, biomedical institutes, clinical labs, and government laboratories. Our advertisers include leading suppliers of research tools, analytical instruments, information technology, and molecular diagnostics. GenomeWeb is a business unit of Crain Communications.

View staff listing


  • Postal Deliveries: PO Box 998, Peck Slip Station, New York, NY 10272-0998
  • Street Address: 1 Battery Park Plaza, 8th Floor, New York, NY 10004

  • Phone: +1-212-269-4747
  • Fax: +1-212-269-3686

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.